April 2016

New Product - Flebogamma 10% DIF

Flebogamma 10% DIF (human normal immunoglobulin) is a preparation of highly purified immunoglobulin (IgG) obtained from human plasma pools. It is indicated as replacement therapy in primary immunodeficiency diseases and in symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment. It is also indicated for immunomodulation in idiopathic thrombocytopaenic purpura, in patients at high risk of bleeding or prior to surgery to correct the platelet count, Guillain-Barré syndrome and in Kawasaki disease. Flebogamma 10% DIF is contraindicated in very rare cases of IgA deficiency and hereditary fructose intolerance. Flebogamma 10% DIF solution for infusion is available as 5 g/50 mL, 10 g/100 mL and 20 g/200 mL vials in packs of 1’s.

This list is a summary of only some of the changes that have occurred over the last month. Before prescribing, always refer to the full product information.

Copyright © MIMS Australia Pty Ltd. All rights reserved.

MIMS Australia
Level 2, 1 Chandos Street
St Leonards NSW 2065
Phone: 1800 800 629